Densoviruses (DVs) are parvoviruses of arthropods and causative agents of natural epizootics in insects and crustaceans populations. Structurally simple, these small DNA viruses, display a large diversity of genomic sequences, structures and organizations. Such diversity, together with the diversity of their invertebrate hosts, from shrimps to mosquitoes and recently including sea stars, suggests that DVs are largely unknown and ubiquitous in the environment. Densoviruses are considered as a model of choice to study virus-host interactions and their evolution at different scales, from individuals to populations. This review summarizes the knowledge on densovirus biology obtained through mechanistic and global approaches. Finally, the potential use of these viruses as biological control agents against insect pests and disease-vectors are exposed.

Download full-text PDF

Source
http://dx.doi.org/10.1684/vir.2015.0589DOI Listing

Publication Analysis

Top Keywords

les densovirus 
4
densovirus  une
4
une « massive
4
« massive attaque »
4
attaque » chez
4
chez les
4
les arthropodes
4
arthropodes densoviruses
4
densoviruses dvs
4
dvs parvoviruses
4

Similar Publications

Exploration of the Role of Cyclophilins in Established Hepatitis B and C Infections.

Viruses

December 2024

INSERM U1052, CNRS UMR5286, Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Lyon Hepatology Institute (IHU Everest), 69003 Lyon, France.

Cyclophilin (Cyp) inhibitors are of clinical interest in respect to their antiviral activities in the context of many viral infections including chronic hepatitis B and C. Cyps are a group of enzymes with peptidyl-prolyl isomerase activity (PPIase), known to be required for replication of diverse viruses including hepatitis B and C viruses (HBV and HCV). Amongst the Cyp family, the molecular mechanisms underlying the antiviral effects of CypA have been investigated in detail, but potential roles of other Cyps are less well studied in the context of viral hepatitis.

View Article and Find Full Text PDF

Inflammatory bowel diseases (IBD) including Crohn's disease (CD) and ulcerative colitis (UC) are chronic, relapsing conditions characterized by dysregulated immune responses and persistent intestinal inflammation. This review aims to examine new potential therapeutic targets in IBD starting from the STRIDE-II statements. Key targets now include clinical remission, endoscopic remission, and biomarker normalization (such as C-reactive protein and fecal calprotectin).

View Article and Find Full Text PDF

Gastroesophageal reflux disease (GERD) affects millions globally, with traditional treatments like proton pump inhibitors (PPIs) and surgical fundoplication presenting challenges such as long-term medication dependency and disturbing long term side effects following surgery. This review explores emerging, alternative therapies that offer less invasive, personalized alternatives for GERD management. Endoscopic approaches, including Stretta therapy, transoral incisionless fundoplication (TIF), and endoscopic full-thickness plication (EFTP), demonstrate promising but also controversial outcomes in symptom relief and reduced acid exposure.

View Article and Find Full Text PDF

In this study, we report the first example of acyclic (amino)(N-pyridinium)carbenoid gold(III) complexes synthesized via a coupling reaction between 2-pyridylselenyl chloride and Au(I)-bound isonitriles. The reaction involves an initial oxidative addition of the Se-Cl moiety to Au(I), followed by the nucleophilic addition of the pyridine fragment to the isonitrile's C≡N bond, furnishing a metallacycle. Importantly, this is the first example of the pyridine acting as a nucleophile towards metal-bound isonitriles.

View Article and Find Full Text PDF

The most severe form of muscular dystrophy (MD), known as Duchenne MD (DMD), remains an incurable disease, hence the ongoing efforts to develop supportive therapies. The dysregulation of autophagy, a degradative yet protective mechanism activated when tissues are under severe and prolonged stress, is critically involved in DMD. Treatments that harness autophagic capacities therefore represent a promising therapeutic approach.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!